Dimensional Fund Advisors
APLT

Dimensional Fund Advisors’s Applied Therapeutics APLT Stock Holding History

Dimensional Fund Advisors’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-36,961
Closed -$35K – 3492
2022
Q2 		$35K Sell
36,961
-2,349
-6% -$3.85K ﹤0.01% 3421
2022
Q1 		$83K Sell
39,310
-33,615
-46% -$90K ﹤0.01% 3412
2021
Q4 		$653K Buy
72,925
+22,741
+45% +$299K ﹤0.01% 3115
2021
Q3 		$832K Buy
50,184
+34,521
+220% +$596K ﹤0.01% 3084
2021
Q2 		$325K Buy
+15,663
New +$296K ﹤0.01% 3248

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Dimensional Fund Advisors's APLT Position: Q3 2022 in Review

Dimensional Fund Advisors sold out of Applied Therapeutics (APLT) in Q3 2022, closing a stake of 36,961 shares — an estimated $35K sold.

Dimensional Fund Advisors first reported a position in APLT in Q2 2021 and held it in 5 quarters. The position peaked at $832K in Q3 2021. 44 funds tracked by Wall St. Rank hold APLT as of Q3 2022.

  • Dimensional Fund Advisors reported no remaining Applied Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 36,961 Applied Therapeutics shares in Q3 2022, an estimated $35K.
  • Dimensional Fund Advisors first reported a position in Applied Therapeutics in Q2 2021 and held it in 5 quarters.
  • Dimensional Fund Advisors's Applied Therapeutics position peaked at $832K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.